Jefferies upgraded Crinetics Pharmaceuticals stock, moving the rating from Hold to Buy, while maintaining a price target of $55.00. The decision follows a notable decline in share price from $60 to ...
The sporting-goods company surpassed its own profit expectations amid fierce competition in the sector and as its biggest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback